Leon Toussaint, Ph.D., is Science Program Manager at the AIM-HI Accelerator Fund, where he supports the scientific evaluation, management, and advancement of innovative cancer research programs and translational efforts in collaboration with the National Foundation for Cancer Research. He works at the intersection of translational science, scientific due diligence, and strategic program development, helping identify and accelerate promising discoveries from the laboratory toward clinical application.
Dr. Toussaint brings more than 20 years of experience in oncology, immunology, translational research, and biomarker development. Previously he held scientific management positions at Advanced Bioscience Laboratories, Champions Oncology, and FlowMetric Life Sciences, where he directed complex immunology and oncology research programs, developed biomarker strategies, and contributed to regulatory and translational initiatives. He has extensive experience evaluating preclinical and clinical data, assessing scientific rigor, and supporting multidisciplinary research portfolios.
Dr. Toussaint earned his Ph.D. in Pathobiology from Brown University and completed postdoctoral training at Cornell University. He has authored numerous peer-reviewed publications spanning immunology, infectious disease, neuroinflammation, and cancer research, and is committed to advancing innovative science that improves outcomes for patients worldwide.
